Literature DB >> 32653526

Reply to letters regarding our paper "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Societyˮ.

Aditya Kapoor1, Ulhas Pandurangi2, Vanita Arora3, Anoop Gupta4, Aparna Jaswal5, Ashish Nabar6, Ajay Naik7, Nitish Naik8, Narayanan Namboodiri Kk9, Amit Vora10, Rakesh Yadav8, Anil Saxena11.   

Abstract

Entities:  

Keywords:  COVID-19; Hydroxychloroquine; QTc interval

Year:  2020        PMID: 32653526      PMCID: PMC7347489          DOI: 10.1016/j.ipej.2020.06.007

Source DB:  PubMed          Journal:  Indian Pacing Electrophysiol J        ISSN: 0972-6292


× No keyword cloud information.
The authors thank Gupta et al. [1] and Mahendran et al. [2] for their interest and comments on our paper titled ‘Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society’ [3] Authors of both letters have raised similar points regarding method to compute QTc interval. We agree that there are numerous formulae that attempt to correct QT for heart rate using exponential methods [4,5,12], linear correlation [[6], [7], [8], [9]], logarithmic correction [10], and others [11]. There is considerable disagreement on which method is best for this purpose. As such, QTc is a derived value computed by one of these formulae. Therefore, in absence of a direct measurement of QTc, or a gold standard for reference, it is nearly impossible to prove superiority of any method for accuracy. There are no large studies confirming superiority of one method over others in a consistent manner. Most clinical studies have used the Bazett’s formula for QTc correction and most outcome data that have associated risk of arrhythmic events based on QTc values in a LQT population are based on this formula. Bazett’s formula was the first and remains most widely recognized and used method. It is mentioned in all current Cardiology and ECG textbooks, and also specifically recommended to calculate Schwartz score for diagnosis of long QT syndrome [13]. It is also the default formula for most QT interval correction apps. Since the guidelines are meant for a wider audience including general physicians, the emphasis was on simplicity. Also, the paper is not primarily about QT interval, but on how to risk stratify and monitor COVID-19 suspects or patients who are to receive hydroxychloroquine for their treatment or prophylaxis. A detailed exposition of merits and demerits of different methods to compute QTc interval would have been a digression from the primary focus of the guidelines.

Contribution of authors

All the authors have prepared the reply jointly and agree on it.

Declaration of competing interest

None of the authors have any conflict of interest.
  8 in total

Review 1.  The duration of the QT interval as a function of heart rate: a derivation based on physical principles and a comparison to measured values.

Authors:  S J Kovács
Journal:  Am Heart J       Date:  1985-10       Impact factor: 4.749

Review 2.  Diagnostic criteria for the long QT syndrome. An update.

Authors:  P J Schwartz; A J Moss; G M Vincent; R S Crampton
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

3.  The duration of systole in an electrocardiogram in normal humans and in patients with heart disease. 1920.

Authors:  L S Fridericia
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-10       Impact factor: 1.468

4.  Assessment of prolonged QT and JT intervals in ventricular conduction defects.

Authors:  Pentti M Rautaharju; Zhu-Ming Zhang; Ron Prineas; Gerardo Heiss
Journal:  Am J Cardiol       Date:  2004-04-15       Impact factor: 2.778

5.  An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

Authors:  A Sagie; M G Larson; R J Goldberg; J R Bengtson; D Levy
Journal:  Am J Cardiol       Date:  1992-09-15       Impact factor: 2.778

6.  Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?

Authors:  Anunay Gupta; Jyothi Vijay; Sourabh Agstam
Journal:  Indian Pacing Electrophysiol J       Date:  2020-07-01

7.  HCQ induced QT prolongation- Primum non nocere.

Authors:  A J Mahendran; Nitesh Gupta; Pranav Ish
Journal:  Indian Pacing Electrophysiol J       Date:  2020-07-01

8.  Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society.

Authors:  Aditya Kapoor; Ulhas Pandurangi; Vanita Arora; Anoop Gupta; Aparna Jaswal; Ashish Nabar; Ajay Naik; Nitish Naik; Narayanan Namboodiri; Amit Vora; Rakesh Yadav; Anil Saxena
Journal:  Indian Pacing Electrophysiol J       Date:  2020-04-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.